UPI - Sep 28 2:39 PM
WASHINGTON, Sept. 28 (UPI) Analysts expect Amgen s Vectibix, which was approved by the Food and Drug Administration for third-line therapy for colon cancer, to steal significant market share from ImClone s Erbitux.Save to My Web
Chicago Sun-Times - Oct 03 2:09 AM
Charles L.
Rodriguez s shy, quiet nature revealed little of his interesting past. Mr. Rodriguez grew up poor in Texas, delivered wine for a company associated with Chicago gangster Ralph Capone Al s brother and spent nine months at a Nazi prison camp in World War II.
Save to My Web
Miami Herald - Oct 02 4:05 AM
James Lamar Shuler, a Delray Beach civic and business leader and husband of former Miami-Dade Commissioner Barbara Carey-Shuler, died Sunday after a long battle with cancer. He was 53.Save to My Web
Antara News - Oct 02 7:51 PM
(Full text of a statement.
Contact details follow below.) Istanbul (ANTARA News/PRNewswire-AsiaNet) - Results from an international, Phase III study presented for the first time today at the European Society for Medical Oncology (ESMO) meeting, show that two innovative cancer drugs, Xeloda and Avastin, are set to provide new effective treatment options for patients with advanced colorectal cancer Save to My Web
The Motley Fool via Yahoo! News - Sep 29 8:11 AM
How often do you see a pharmaceutical company s drug receive marketing approval and then watch a rival s shares end up in positive territory for the day as well?
Not very often, but shares of ImClone Systems (Nasdaq: IMCL - News) did just that yesterday.
News RSS